HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- (2- (3,5- dimethyl- 1- adamantyl)ethyl)acetamidine

a voltage-dependent NMDA receptor antagonist

Also Known As:

CR 3394; CR-3394; CR3394

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Alicyclic Hydrocarbons: 1
      - Cycloparaffins: 6
        Adamantane: 182
        N-(2-(3,5-dimethyl-1-adamantyl)ethyl)acetamidine: 1
    - Bridged-Ring Compounds: 1
      - Adamantane: 182
        N-(2-(3,5-dimethyl-1-adamantyl)ethyl)acetamidine: 1
- Amidines: 14
  - N-(2-(3,5-dimethyl-1-adamantyl)ethyl)acetamidine: 1

Experts

1.	Artusi, Roberto: 1 article (03/2006)
2.	Caselli, Gianfranco: 1 article (03/2006)
3.	Lanza, Marco: 1 article (03/2006)
4.	Losi, Gabriele: 1 article (03/2006)
5.	Makovec, Francesco: 1 article (03/2006)
6.	Puia, Giulia: 1 article (03/2006)

Related Diseases

1.	Neurodegenerative Diseases (Neurodegenerative Disease) 03/01/2006 - "Taken together, our data highlight pharmacological features of CR 3394 in vitro that prompt us to further evaluate it as a candidate for the treatment of neurodegenerative disorders."